KATHRYN TUTTLE: Open Payments
NPI 1154956977 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 57 payments from 16 companies in 2025. Trend: 2023 $982 · 2024 $1,253 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $228 |
| Amgen Inc. | 12 | $202 |
| GlaxoSmithKline, LLC. | 8 | $138 |
| ABBVIE INC. | 5 | $102 |
| Novo Nordisk Inc | 5 | $93 |
| Exact Sciences Corporation | 3 | $76 |
| Lilly USA, LLC | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Inspire Medical Systems, Inc. | 1 | $45 |
| Esperion Therapeutics, Inc. | 1 | $24 |
Products named: OTEZLA, BREZTRI, TRELEGY ELLIPTA, FARXIGA, Cologuard Collection Kit, XIFAXAN, INSPIRE, VRAYLAR.
Industry payments across FL — which companies pay providers there.
